{"title":"Genetic disorders and congenital anomalies in Nigeria: a scoping review.","authors":"Ayoade Desmond Babalola, Nitza Ferreira Muniz, Lavinia Schuler-Faccini","doi":"10.1007/s12687-026-00876-w","DOIUrl":null,"url":null,"abstract":"<p><p>Nigeria, with its rich cultural and genetic diversity, faces a largely undocumented burden of genetic disorders and congenital anomalies. Understanding this burden is vital for effective healthcare planning and interventions. The aim of this study was to provide a comprehensive overview of the prevalence and geographical distribution of genetic disorders and congenital anomalies in Nigeria based on published evidence. A systematic scoping review was conducted across seven databases using tailored search strategies. Screening was performed in two stages: (1) title and abstract and (2) full text- prior to data extraction and analysis. Prevalence figures were recalculated and standardized as a percentage of live births or individuals. Seventy-eight studies met the inclusion criteria, of which 27 reported at least one genetic disorder. Hemoglobinopathies–particularly sickle cell disease (SCD) and sickle cell traits–were the most frequently reported conditions, with prevalence estimates as high as 61%, underscoring Nigeria’s substantial disease burden. Glucose-6-phosphate dehydrogenase (G6PD) deficiency was also commonly reported, with prevalence reaching up to 60% in some populations. Congenital anomalies involving the central nervous system, musculoskeletal system, cardiovascular system, and genitourinary tract were frequently described, with reported prevalence estimates of up to 13%, 8.8%, 3% and 6.7%, respectively. Geographically, studies were disproportionately concentrated in the southern regions, while northern areas–particularly the Northeast–were markedly underrepresented. Significant regional and condition-specific knowledge gaps persist regarding genetic disorders and congenital anomalies in Nigeria, especially in the North. Strengthening surveillance systems, expanding regionally representative research, and implementing targeted public health interventions are critical to inform equitable healthcare planning and reduce disease burden.</p>","PeriodicalId":46965,"journal":{"name":"Journal of Community Genetics","volume":"17 2","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2026-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13062147/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Community Genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12687-026-00876-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Nigeria, with its rich cultural and genetic diversity, faces a largely undocumented burden of genetic disorders and congenital anomalies. Understanding this burden is vital for effective healthcare planning and interventions. The aim of this study was to provide a comprehensive overview of the prevalence and geographical distribution of genetic disorders and congenital anomalies in Nigeria based on published evidence. A systematic scoping review was conducted across seven databases using tailored search strategies. Screening was performed in two stages: (1) title and abstract and (2) full text- prior to data extraction and analysis. Prevalence figures were recalculated and standardized as a percentage of live births or individuals. Seventy-eight studies met the inclusion criteria, of which 27 reported at least one genetic disorder. Hemoglobinopathies–particularly sickle cell disease (SCD) and sickle cell traits–were the most frequently reported conditions, with prevalence estimates as high as 61%, underscoring Nigeria’s substantial disease burden. Glucose-6-phosphate dehydrogenase (G6PD) deficiency was also commonly reported, with prevalence reaching up to 60% in some populations. Congenital anomalies involving the central nervous system, musculoskeletal system, cardiovascular system, and genitourinary tract were frequently described, with reported prevalence estimates of up to 13%, 8.8%, 3% and 6.7%, respectively. Geographically, studies were disproportionately concentrated in the southern regions, while northern areas–particularly the Northeast–were markedly underrepresented. Significant regional and condition-specific knowledge gaps persist regarding genetic disorders and congenital anomalies in Nigeria, especially in the North. Strengthening surveillance systems, expanding regionally representative research, and implementing targeted public health interventions are critical to inform equitable healthcare planning and reduce disease burden.
期刊介绍:
The Journal of Community Genetics is an international forum for research in the ever-expanding field of community genetics, the art and science of applying medical genetics to human communities for the benefit of their individuals.
Community genetics comprises all activities which identify persons at increased genetic risk and has an interest in assessing this risk, in order to enable those at risk to make informed decisions. Community genetics services thus encompass such activities as genetic screening, registration of genetic conditions in the population, routine preconceptional and prenatal genetic consultations, public education on genetic issues, and public debate on related ethical issues.
The Journal of Community Genetics has a multidisciplinary scope. It covers medical genetics, epidemiology, genetics in primary care, public health aspects of genetics, and ethical, legal, social and economic issues. Its intention is to serve as a forum for community genetics worldwide, with a focus on low- and middle-income countries.
The journal features original research papers, reviews, short communications, program reports, news, and correspondence. Program reports describe illustrative projects in the field of community genetics, e.g., design and progress of an educational program or the protocol and achievement of a gene bank. Case reports describing individual patients are not accepted.